As shown in Supplemental Table 3 , even after excluding patients with lower serum P levels, PS-based analysis demonstrated significant or marginally significant associations between treatment with P-binders and a reduced risk of infection-related and all-cause mortality (Supplementary Table 3 ).
← all excerpts
Use of phosphate-binders and risk of infection-related and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort Study.
1
—
—